Search results
Results From The WOW.Com Content Network
Alcohol withdrawal delirium: 291.89: Alcohol-induced anxiety disorder: Coded 291.8 in the DSM-IV. 291.89: Alcohol-induced mood disorder: Coded 291.8 in the DSM-IV. 291.1: Alcohol-induced persisting amnestic disorder: 291.2: Alcohol-induced persisting dementia: 291.x: Alcohol-induced psychotic disorder: 291.5: Alcohol-induced psychotic disorder ...
Alcohol dependence is a previous (DSM-IV and ICD-10) psychiatric diagnosis in which an individual is physically or psychologically dependent upon alcohol (also chemically known as ethanol). In 2013, it was reclassified as alcohol use disorder in DSM-5 , [ 1 ] which combined alcohol dependence and alcohol abuse into this diagnosis.
294.1x Dementia due to head trauma (coded 294.1 in the DSM-IV) 294.1x Dementia due to Parkinson's disease (coded 294.9 in the DSM-IV) 294.1x Dementia due to Huntington's disease (coded 294.1 in the DSM-IV) 294.1x Dementia due to Pick's disease (coded 290.10 in the DSM-IV) 294.1x Dementia due to Creutzfeldt–Jakob disease (coded 290.10 in the ...
Psychoactive substance-induced psychotic disorders outlined within the ICD-10 codes F10.5—F19.5: F10.5 alcohol: [8] [9] [10] Alcohol is a common cause of psychotic disorders or episodes, which may occur through acute intoxication, chronic alcoholism, withdrawal, exacerbation of existing disorders, or acute idiosyncratic reactions. [8]
Management with a combination of abstinence from alcohol and the use of neuroleptics has been shown to be effective. [11] It is also possible to treat withdrawal before major symptoms start to happen in the body. Diazepam and chlordiazepoxide have proven to be effective in treating alcohol withdrawal symptoms such as alcoholic hallucinosis ...
Failure to manage the alcohol withdrawal syndrome appropriately can lead to permanent brain damage or death. [48] It has been proposed that brain damage due to alcohol withdrawal may be prevented by the administration of NMDA antagonists, calcium antagonists, and glucocorticoid antagonists. [49]
Marchiafava–Bignami disease (MBD) is a progressive neurological disease of alcohol use disorder, characterized by corpus callosum demyelination and necrosis and subsequent atrophy. The disease was first described in 1903 by the Italian pathologists Amico Bignami and Ettore Marchiafava in an Italian Chianti drinker.
Alcohol abuse was a psychiatric diagnosis in the DSM-IV, but it has been merged with alcohol dependence in the DSM-5 into alcohol use disorder. [ 2 ] [ 3 ] Globally, excessive alcohol consumption is the seventh leading risk factor for both death and the burden of disease and injury, [ 4 ] representing 5.1% of the total global burden of disease ...